↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$804.00Sold on the market
1Companies
Aug 20, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 202616:08 | Aug 18, 2026 | ACRVAcrivon Therapeutics, Inc. | Chief Development Officer | S · Sell | $2.01 | −400 | 52,592 | -1% | −$804.00 |